Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Chimeric Antigen Receptor T-Cell Therapies for Cancer

Chimeric Antigen Receptor T-Cell Therapies for Cancer

A Practical Guide

9780323661812
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 30 DAYS
357.79 zł
304.12 zł Save 53.67 zł Tax included
Lowest price within 30 days before promotion: 304.12 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DHL, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

From patient referral to post-therapy management, Chimeric Antigen Receptor (CAR) T-Cell Therapies for Cancer:: A Practical Guide presents a comprehensive view of CAR modified T-cells in a concise and practical format. Providing authoritative guidance on the implementation and management of CAR T-cell therapy from Drs. Daniel W. Lee and Nirali N. Shah, this clinical resource keeps you up to date on the latest developments in this rapidly evolving area.

Product Details
Elsevier
80868
9780323661812
9780323661812

Data sheet

Publication date
2019
Issue number
1
Cover
paperback
Pages count
244
Dimensions (mm)
191 x 235
Weight (g)
500

  • Introduction
    1. When to Refer a Patient for CAR-T Cell Therapy
    2. Optimizing the Apheresis Product
    3. CAR T Cells: Cell Processing Laboratory Considerations
    4. Peri-CAR-T Cell Management
    5. Management of Cytokine Release Syndrome
    6. Special Considerations for ICU Management of Patients Receiving CAR Therapy
    7. Neurotoxicities After CAR-T Cell Immunotherapy
    8. Hematologic and Non-CRS Toxicities
    9. Response Assessment and PosteCAR-T Cell Therapy Management
    10. Relapse Management and Role for Consolidative Hematopoietic Stem Cell Transplantation Following CAR-T Cell Therapy
    11. Promising Chimeric Antigen Receptors for Non-B Cell Hematological Malignancies, Pediatric Solid Tumors, and Carcinomas
    12. CAR T Cell Therapy for CNS Malignancies
    13. CAR 2.0: The Next Generation of Synthetic ReceptoreBased Cellular Therapy for Cancer

Comments (0)
Viewed products

  • Frequently purchased together

    No products available